History of cardiovascular disease or at risk of cardiovascular and elevated Lp(a)
Ongoing
-
Adelaide SA | Goolwa SA
Trialling a new medication on elevated Lp(a) in people with CVD or at risk of CVD.
- Pre-screening / Screening visit
- Injections every 6 months
- Age < 55 years
- Individuals at risk for a first cardiovascular (CV) event, as determined at screening
Outpatient Visit
- Clinic visits every 3 months
- Injections every 6 months
- Continue until end of trial
Payment / Remuneration
- Travel payment provided for each visit
- Regional participants reimbursed per km and overnight accommodation if required